Yukihiko Aramaki Selected Research

Ischemia

1/2014	Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia.
6/2012	Systemic delivery systems of angiogenic gene by novel bubble liposomes containing cationic lipid and ultrasound exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukihiko Aramaki Research Topics

Disease

14	Neoplasms (Cancer) 01/2014 - 04/2006
4	Inflammation (Inflammations) 01/2007 - 10/2005
3	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2015
3	Atopic Dermatitis (Atopic Eczema) 01/2007 - 10/2005
2	Muscular Dystrophies (Muscular Dystrophy) 03/2014 - 01/2012
2	Ischemia 01/2014 - 06/2012
2	Hepatocellular Carcinoma (Hepatoma) 12/2012 - 03/2003
1	Pneumococcal Infections 08/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2014
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2014
1	Carcinogenesis 01/2012
1	Mucositis 05/2011
1	Ovarian Neoplasms (Ovarian Cancer) 05/2011
1	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2011
1	Arthritis (Polyarthritis) 11/2010
1	Bacteremia 09/2009
1	Sepsis (Septicemia) 09/2009
1	Skin Diseases (Skin Disease) 01/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2006
1	Hepatoblastoma 03/2003

Drug/Important Bio-Agent (IBA)

16	Liposomes (Liposome)IBA 08/2018 - 03/2003
5	Peptides (Polypeptides)IBA 07/2013 - 02/2010
5	CPG-oligonucleotideIBA 03/2007 - 10/2005
4	VaccinesIBA 01/2021 - 01/2015
4	Syndecan-2IBA 05/2011 - 01/2010
3	AntigensIBA 08/2018 - 10/2005
3	LigandsIBA 05/2011 - 02/2010
3	CytokinesIBA 11/2010 - 10/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2013 - 05/2011
2	Laminin (Merosin)IBA 05/2011 - 08/2010
2	SyndecansIBA 05/2011 - 02/2010
1	PolyphenolsIBA 01/2021
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 08/2018
1	3- (N- (N',N'- dimethylaminoethane)carbamoyl)cholesterolIBA 08/2018
1	pneumococcal surface protein AIBA 08/2018
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Biocompatible Materials (Biomaterials)IBA 07/2013
1	Contrast MediaIBA 07/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2012
1	contrast agent BR1IBA 12/2012
1	SolutionsIBA 06/2012
1	IntegrinsIBA 05/2012
1	aspartyl- phenylalanyl- lysyl- leucyl- phenylalanyl- alanyl- valyl- tyrosyl- isoleucyl- lysyl- tyrosyl- arginineIBA 05/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Nucleic AcidsIBA 01/2012
1	ChemokinesIBA 01/2012
1	liposomal doxorubicin (Doxil)FDA Link 05/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2010
1	laminin AIBA 02/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2009
1	Clodronic Acid (Clodronate)IBA 09/2009
1	Interleukin-1 (Interleukin 1)IBA 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2009
1	Interleukin-6 (Interleukin 6)IBA 09/2009
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2007
1	ProstaglandinsIBA 03/2007
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2007
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2007
1	OligodeoxyribonucleotidesIBA 01/2007
1	Immunoglobulin E (IgE)IBA 01/2007
1	poly(ethylene glycol)-folateIBA 04/2006
1	stearylamineIBA 04/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2006
1	Immunoglobulin IsotypesIBA 10/2005
1	Cyclin AIBA 03/2003
1	Asialoglycoprotein ReceptorIBA 03/2003

Therapy/Procedure

9	Therapeutics 03/2014 - 03/2007
1	Microbubbles 12/2012
1	Immunotherapy 01/2007